Debio1347, an oral FGFR inhibitor: Results from a single center study in recurrent/refractory FGFR altered pediatric glioma Meeting Abstract


Authors: Sait, S. F.; Gilheeney, S.; Bale, T.; Rosenblum, M.; Haque, S.; Ibanez, K.; Dinkin, M.; Vitolano, S.; Dunkel, I.; Karajannis, M.
Abstract Title: Debio1347, an oral FGFR inhibitor: Results from a single center study in recurrent/refractory FGFR altered pediatric glioma
Meeting Title: Society for Neuro-Oncology’s 6th Biennial Pediatric Neuro-Oncology Basic and Translational Research Conference
Journal Title: Neuro-Oncology
Volume: 23
Issue: Suppl. 1
Meeting Dates: 2021 Jun 10-12
Meeting Location: Virtual
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2021-06-01
Start Page: i48
End Page: i49
Language: English
ACCESSION: WOS:000671540600197
DOI: 10.1093/neuonc/noab090.196
PROVIDER: wos
Notes: Meeting Abstract: EPCT-10 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ira J Dunkel
    371 Dunkel
  2. Marc Rosenblum
    424 Rosenblum
  3. Sofia S Haque
    148 Haque
  4. Katarzyna   Ibanez
    18 Ibanez
  5. Tejus Bale
    122 Bale